Low levels of brain protein may lead to Alzheimer's

Feb 15, 2011

In Alzheimer’s disease, short, toxic amyloid beta peptides build up inside the brain, erasing memories, altering behavior, and ultimately destroying lives.

Scientists have a good idea how toxic amyloid beta is created, but what’s not clear is why excessive amounts of amyloid beta accumulate in people who develop Alzheimer’s. After all, each of us produces some degree of the toxic protein throughout our lives.

Now findings suggest that amyloid beta may accumulate in some patients because of a flaw in their neurons’ internal transportation system, according to a new study from researchers in the Taub Institute at Columbia University College of Physicians and Surgeons and the University of Toronto. The study was led by Christiane Reitz, MD, assistant professor of neurology, and Richard Mayeux, MD, the Sergievsky Professor of Neurology, Psychiatry, and Epidemiology and co-director of the Taub Institute of Research on and the Aging Brain at P&S, and was published in the Jan. issue of the .

Like all cells, neurons use transport proteins to ship cellular components from one region of the cell to another. The shipping process is critical to the production of amyloid beta: transport proteins must carry the amyloid precursor protein (APP) to certain regions of the cell where the protein is processed into soluble forms of amyloid beta.

The new research reveals that a different transport protein, called SORCS1, appears to ferry APP to safe destinations within the cell where it’s sliced into non-toxic pieces instead of amyloid beta.

Alzheimer’s patients appear to express reduced levels of SORCS1 in their brains, Reitz and Mayeux also found, suggesting that APP in patients is more likely to be shipped to cellular compartments that process the protein into toxic amyloid.

Genetic studies included in the paper also show that people who carry certain variants of the SORCS1 gene have a 15 percent greater risk of developing Alzheimer’s.
Taken together, Mayeux says the results show that APP transport proteins are key players in the development of Alzheimer’s disease, especially when considered with similar findings for a related transport protein called SORL1. (The same Columbia and Toronto research group discovered the SORL1 link four years ago).

Increasing SORCS1 or SORL1 activity could potentially reduce the amount of amyloid beta in the and slow or prevent Alzheimer’s. SORCS1 and SORL1 may be hard to target directly, but other proteins in the SORCS1-SORL1 network could provide better opportunities, Mayeux says.

The researchers are now collaborating with Columbia’s Initiative in Systems Biology 
and Center for the Multiscale Analysis of Genetic Networks to map the entire network and identify promising targets.

Explore further: Know the brain, and its axons, by the clothes they wear

add to favorites email to friend print save as pdf

Related Stories

Development of a safer vaccine for Alzheimer’s disease

Nov 17, 2010

A new vaccine protects against memory problems associated with Alzheimer's disease, but without potentially dangerous side effects, a new animal study reports. The research was presented at Neuroscience 2010, the annual meeting ...

Alzheimer's prevention role discovered for prions

Jul 03, 2007

A role for prion proteins, the much debated agents of mad cow disease and vCJD, has been identified. It appears that the normal prions produced by the body help to prevent the plaques that build up in the brain to cause Alzheimer’s ...

New approach to Alzheimer's therapy

Jul 30, 2010

Researchers from the German Centre for Neurodegenerative Diseases and the Ludwig-Maximilians-Universitat in Munich have shown that the ADAM10 protein can inhibit the formation of beta-amyloid, which is responsible for Alzheimer's ...

Recommended for you

Know the brain, and its axons, by the clothes they wear

Apr 18, 2014

(Medical Xpress)—It is widely know that the grey matter of the brain is grey because it is dense with cell bodies and capillaries. The white matter is almost entirely composed of lipid-based myelin, but ...

Turning off depression in the brain

Apr 17, 2014

Scientists have traced vulnerability to depression-like behaviors in mice to out-of-balance electrical activity inside neurons of the brain's reward circuit and experimentally reversed it – but there's ...

Rapid whole-brain imaging with single cell resolution

Apr 17, 2014

A major challenge of systems biology is understanding how phenomena at the cellular scale correlate with activity at the organism level. A concerted effort has been made especially in the brain, as scientists are aiming to ...

User comments : 0

More news stories

Less-schooled whites lose longevity, study finds

Barbara Gentry slowly shifts her heavy frame out of a chair and uses a walker to move the dozen feet to a chair not far from the pool table at the Buford Senior Center. Her hair is white and a cough sometimes interrupts her ...

How to keep your fitness goals on track

(HealthDay)—The New Year's resolutions many made to get fit have stalled by now. And one expert thinks that's because many people set their goals too high.

Low tolerance for pain? The reason may be in your genes

Researchers may have identified key genes linked to why some people have a higher tolerance for pain than others, according to a study released today that will be presented at the American Academy of Neurology's 66th Annual ...

AMA examines economic impact of physicians

(HealthDay)—Physicians who mainly engage in patient care contribute a total of $1.6 trillion in economic output, according to the American Medical Association (AMA)'s Economic Impact Study.

Making graphene in your kitchen

Graphene has been touted as a wonder material—the world's thinnest substance, but super-strong. Now scientists say it is so easy to make you could produce some in your kitchen.